Formosa Pharmaceuticals and DÁVI Farmacêutica Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain ...Middle East

TAIPEI, Oct. 31, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with DÁVI Farmacêutica ("DÁVI") in Portugal, for exclusive rights to the commercialization of clobetasol...

Read More Details
Finally We wish PressBee provided you with enough information of ( Formosa Pharmaceuticals and DÁVI Farmacêutica Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain )

Also on site :

• Christina Aguilera, 44, Wears Nothing But Leather Lingerie in Racy Photos
• 'Law & Order' Star, 64, Suffers Heartbreaking Family Loss
• Netanyahu confirms Israel arming clans opposed to Hamas in Gaza